Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First AAV gene therapy poised for landmark approval.

Literature DB >> 29121014

First AAV gene therapy poised for landmark approval.

Eric Smalley.

Abstract

Mesh：

Substances：

Year: 2017 PMID： 29121014 DOI： 10.1038/nbt1117-998

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

1 in total

1. Gene therapy 'cure' for blindness wanes.

Authors: Anna Azvolinsky
Journal: Nat Biotechnol Date: 2015-07 Impact factor: 54.908

1 in total

48 in total

1. Establishment of a High-Yield Recombinant Adeno-Associated Virus/Human Bocavirus Vector Production System Independent of Bocavirus Nonstructural Proteins.

Authors: Ziying Yan; Wei Zou; Zehua Feng; Weiran Shen; Soo Yeun Park; Xuefeng Deng; Jianming Qiu; John F Engelhardt
Journal: Hum Gene Ther Date: 2019-01-31 Impact factor: 5.695

2. rAAV6-mediated miR-29b delivery suppresses renal fibrosis.

Authors: Suguru Saito; Shin-Ichiro Ohno; Yuichirou Harada; Keiki Oikawa; Koji Fujita; Shouichirou Mineo; Asako Gondo; Yoshihiko Kanno; Masahiko Kuroda
Journal: Clin Exp Nephrol Date: 2019-09-03 Impact factor: 2.801

3. FDA approves hereditary blindness gene therapy.

Authors:
Journal: Nat Biotechnol Date: 2018-01-10 Impact factor: 54.908

4. Targeted tPA overexpression in denervated spinal motor neurons promotes stroke recovery in mice.

Authors: Xinling Gan; Michael Chopp; Hongqi Xin; Fengjie Wang; William Golembieski; Mei Lu; Li He; Zhongwu Liu
Journal: J Cereb Blood Flow Metab Date: 2020-01-27 Impact factor: 6.200

Review 5. Human Cardiac Gene Therapy.

Authors: Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal: Circ Res Date: 2018-08-17 Impact factor: 17.367

10. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.

Authors: Zheng Chai; Xintao Zhang; Kelly Michelle Rigsbee; Mei Wang; Richard Jude Samulski; Chengwen Li
Journal: J Control Release Date: 2018-08-11 Impact factor: 9.776

First AAV gene therapy poised for landmark approval.

1. Gene therapy 'cure' for blindness wanes.

1. Establishment of a High-Yield Recombinant Adeno-Associated Virus/Human Bocavirus Vector Production System Independent of Bocavirus Nonstructural Proteins.

2. rAAV6-mediated miR-29b delivery suppresses renal fibrosis.

3. FDA approves hereditary blindness gene therapy.

4. Targeted tPA overexpression in denervated spinal motor neurons promotes stroke recovery in mice.

Review 5. Human Cardiac Gene Therapy.

6. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

7. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.

Review 8. THE JEREMIAH METZGER LECTURE NOVEL THERAPEUTIC STRATEGIES OF ALLERGIC AND IMMUNOLOGIC DISORDERS.

9. Neutralisation of adeno-associated virus transduction by human vitreous humour.

10. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.